NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM143171 Query DataSets for GSM143171
Status Public on Nov 03, 2006
Title Gene Transcription Profiles during Development of Mucosal Immunity Slide04 (T5-T8)
Sample type RNA
 
Channel 1
Source name T5
Organism Gallus gallus
Characteristics Ti: RNA derived from chicken trachea tissues at day i (i=1,3,5,8,12,21,22,24) after the initial IBV-Mass inoculation; Ci: Control RNA derived from chicken trachea tissue at day i after inoculation with sterile distilled water.
Note: Chickens were re-inoculated with IBV-Mass at day 21 after the initial immunization. We used pooled control RNA for hybridization.
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from the pooled samples of age-matched control and vaccinated chickens using RNeasy mini tissue kit from QIAGEN Inc. (Valencia, CA). Residue DNA was removed with RNase-free DNase (QIAGEN). The concentration of total RNA was determined using NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE). The quality and quantity of selected RNA samples was examined by gel electrophoresis.
Label Cy3
Label protocol Message RNA amplification was carried out with MessageAmp aminoallyl Amplification Kit (Ambion, #1752). Then, amplified RNA was used for cDNA synthesis, which was subsequently labeled with Cy3 and Cy5 Monoreactive dye (Amersham, # PA23001 and # PA25001). Purification of the cDNA was performed with QIAquick PCR Purification Kit (QIAGEN, #28104). All procedures were performed by following the manufacturers’ instructions.
 
Channel 2
Source name T8
Organism Gallus gallus
Characteristics Ti: RNA derived from chicken trachea tissues at day i (i=1,3,5,8,12,21,22,24) after the initial IBV-Mass inoculation; Ci: Control RNA derived from chicken trachea tissue at day i after inoculation with sterile distilled water.
Note: Chickens were re-inoculated with IBV-Mass at day 21 after the initial immunization. We used pooled control RNA for hybridization.
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from the pooled samples of age-matched control and vaccinated chickens using RNeasy mini tissue kit from QIAGEN Inc. (Valencia, CA). Residue DNA was removed with RNase-free DNase (QIAGEN). The concentration of total RNA was determined using NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE). The quality and quantity of selected RNA samples was examined by gel electrophoresis.
Label Cy5
Label protocol Message RNA amplification was carried out with MessageAmp aminoallyl Amplification Kit (Ambion, #1752). Then, amplified RNA was used for cDNA synthesis, which was subsequently labeled with Cy3 and Cy5 Monoreactive dye (Amersham, # PA23001 and # PA25001). Purification of the cDNA was performed with QIAquick PCR Purification Kit (QIAGEN, #28104). All procedures were performed by following the manufacturers’ instructions.
 
 
Hybridization protocol Hybridization was performed based on the protocol provided by FHCRC (http://www.fhcrc.org/science/shared_resources/genomics/dna_array/spotted_arrays/chicken_array/HybridizationWashProtocol.pdf) with slight modifications. Briefly, nonfat milk was used in pre-hybridization to block non-specific binding sites. For hybridization, the mixture of 20X SSC (6.0µl), 2% SDS (2.4µl) and labeled cDNA samples (5µg for each) was applied to 13k array slide. The total volume was 60µl. Slide was incubated at 63°C for 4hrs followed by incubating at 55°C for 11hrs.
Scan protocol After washing, slides were dried by quick spin and ready for scanning. Arrays were scanned using a GenePix 4000B Microarray Scanner (Molecular Device Corporation, Sunnyvale, CA) and image analysis was performed by using GenePixPro6.0.
Description The goal of the study was to uncover the molecular mechanism of mucosal immunity development using avian infectious bronchitis virus (IBV) as a model system. To achieve this goal, we monitored the kinetics of local gene transcription profiles in trachea tissues after administration of animals with an attenuated IBV strain (IBV-Mass) using chicken 13K cDNA Microarray. More specifically, immune-related gene transcription profiles in trachea at 1, 3, 5, 8, 12 and 21 days after the primary immunization and at 1 and 2 days after a second immunization were characterized. There are total 9 groups including 8 time points for vaccinated groups and 1 pooled age-matched control group. RNAs from each group were used to compare with RNAs from other four groups as determined by the loop-design. Four different RNA samples at each time point were used for hybridization with the respective four other groups. The use of the loop-design allows the direct comparisons between the 9 groups, which would enhance the statistical power and lower the variation. This design is preferred over other methods when the goal of the study is to uncover the kinetics of gene transcription profiles.
Data processing Data were collected using GenePixPro6.0 with the LOWESS normalization.
 
Submission date Oct 30, 2006
Last update date Nov 02, 2006
Contact name Xiuqing Wang
E-mail(s) xiuqing.wang@sdstate.edu
Phone 605-688-5502
Fax 605-688-5624
URL http://www3.sdstate.edu/Academics/CollegeOfAgricultureAndBiologicalSciences/BiologyandMicrobiology/FacultyStaff/WangXiuqing/Index.cfm
Organization name South Dakota State University
Department Department of Biology and Microbiology
Lab Virology lab
Street address NPB 252, SDSU
City Brookings
State/province SD
ZIP/Postal code 57007
Country USA
 
Platform ID GPL1836
Series (1)
GSE6198 Gene Transcription Profiles during Development of Mucosal Immunity

Data table header descriptions
ID_REF
F635 Median median feature pixel intensity at wavelength #1 (635 nm).
F635 Mean mean feature pixel intensity at wavelength #1 (635 nm).
F635 SD the standard deviation of the feature pixel intensity at wavelength #1 (635 nm).
B635 Median the median feature background intensity at wavelength #1 (635 nm).
B635 Mean the mean feature background intensity at wavelength #1 (635 nm).
B635 SD the standard deviation of the feature background intensity at wavelength #1 (635 nm).
F532 Median median feature pixel intensity at wavelength #2 (532 nm).
F532 Mean mean feature pixel intensity at wavelength #2 (532 nm).
F532 SD the standard deviation of the feature intensity at wavelength #2 (532 nm).
B532 Median the median feature background intensity at wavelength #2 (532 nm).
B532 Mean the mean feature background intensity at wavelength #2 (532 nm).
B532 SD the standard deviation of the feature background intensity at wavelength #2 (532 nm).
Ratio of Medians (635/532) the ratio of the median intensities of each feature for each wavelength, with the median background subtracted.
Ratio of Means (635/532) the ratio of the arithmetic mean intensities of each feature for each wavelength, with the median background subtracted.
Median of Ratios (635/532) the median of pixel-by-pixel ratios of pixel intensities, with the median background subtracted.
Mean of Ratios (635/532) the geometric mean of the pixel-by-pixel ratios of pixel intensities, with the median background subtracted.
Ratios SD (635/532) the geometric standard deviation of the pixel intensity ratios.
VALUE log (base 2) transform of the ratio of the medians.
SNR 635 the signal-to-noise ratio at wavelength #1, defined by (Mean Foreground 1- Mean Background 1) / (Standard deviation of Background 1)
SNR 532 the signal-to-noise ratio at wavelength #2, defined by (Mean Foreground 2- Mean Background 2) / (Standard deviation of Background 2)

Data table
ID_REF F635 Median F635 Mean F635 SD B635 Median B635 Mean B635 SD F532 Median F532 Mean F532 SD B532 Median B532 Mean B532 SD Ratio of Medians (635/532) Ratio of Means (635/532) Median of Ratios (635/532) Mean of Ratios (635/532) Ratios SD (635/532) VALUE SNR 635 SNR 532
RUBISCO.9 239 262 108 76 77 22 226 250 109 83 87 25 1.139 1.117 1.154 1.138 2.051 0.188 8.4 6.429
RUBISCO.8 153 160 49 73 76 24 185 194 51 92 95 22 0.85 0.85 0.901 0.811 3.258 -0.235 3.5 4.4
RUBISCO.7 106 112 35 76 78 24 110 124 48 95 98 25 2.002 1.254 1.116 1.133 3.614 1.002 1.409 1
RUBISCO.6 136 135 49 77 76 22 130 142 31 82 87 25 1.239 0.976 1.311 0.85 4.809 0.309 2.7 2.143
RUBISCO.5 212 224 80 79 80 26 233 226 68 88 92 28 0.919 1.056 0.886 1.011 2.093 -0.121 5.458 4.774
RUBISCO.4 167 186 82 68 73 24 172 194 90 77 81 20 1.052 1.008 1.175 1.082 2.847 0.073 4.636 5.435
RUBISCO.32 101 102 29 63 68 22 136 134 26 81 82 19 0.689 0.734 0.845 0.652 4.697 -0.538 1.55 2.714
RUBISCO.31 137 136 44 68 71 24 156 162 39 83 85 19 0.946 0.866 0.905 0.868 2.777 -0.081 2.682 3.864
RUBISCO.30 117 134 60 65 68 22 142 155 50 80 81 19 0.858 0.934 1.12 0.861 3.186 -0.221 3 3.682
RUBISCO.3 80 88 39 77 89 59 92 100 44 89 103 58 1.216 1.013 0.912 1.096 4.178 0.282 -0.019 -0.047
RUBISCO.29 162 183 88 65 69 23 176 204 105 78 81 22 0.991 0.943 0.989 1.064 2.584 -0.014 4.905 5.4
RUBISCO.28 67 100 238 69 74 27 87 91 29 84 88 29 -0.811 4.255 0.932 1.251 6.41 0.92 0.094
RUBISCO.27 158 163 57 66 69 22 179 185 61 87 89 20 1.011 0.991 0.885 1.139 3.358 0.016 4.25 4.609
RUBISCO.26 117 126 27 62 67 20 130 126 23 79 80 19 1.086 1.356 1.164 1.095 2.406 0.118 2.842 2.318
RUBISCO.25 111 130 76 70 78 38 135 154 86 83 88 34 0.789 0.842 0.913 0.874 3.774 -0.342 1.343 1.895
RUBISCO.24 101 102 31 72 77 27 110 114 31 88 94 29 1.317 1.172 1.368 1.276 3.229 0.397 0.92 0.688
RUBISCO.23 97 124 82 68 71 22 106 122 56 82 85 19 1.216 1.409 1.331 1.354 3.812 0.282 2.4 1.952
RUBISCO.22 199 223 80 70 73 23 199 208 68 82 84 19 1.103 1.216 1.152 1.333 2.164 0.141 6.476 6.227
RUBISCO.21 123 129 44 77 80 25 139 136 24 85 88 23 0.851 1.002 0.932 1.038 3.132 -0.233 1.913 2.038
RUBISCO.20 133 149 71 68 71 20 155 155 58 79 81 19 0.854 1.084 1.077 1.101 3.495 -0.228 3.737 3.857

Total number of rows: 15769

Table truncated, full table size 1648 Kbytes.




Supplementary file Size Download File type/resource
GSM143171.gpr.gz 1.4 Mb (ftp)(http) GPR
GSM143171.jpg.gz 2.6 Mb (ftp)(http) JPG

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap